Masahito Nagaki
Overview
Explore the profile of Masahito Nagaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
830
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, et al.
J Neurol
. 2013 Jan;
260(6):1611-6.
PMID: 23344626
Gastrointestinal symptoms are frequent complaints in patients with myotonic dystrophy type 1 (MyD1) and may be associated with reduced gastrointestinal motility caused by smooth muscle dysfunction. Although previous studies have...
2.
Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, et al.
J Neurol
. 2012 Jan;
259(7):1448-52.
PMID: 22218651
Autonomic failure is one of the criteria according to the second consensus statement for the diagnosis of multiple system atrophy (MSA). Gastrointestinal symptoms are frequent complaints in patients with MSA...
3.
Suetsugu A, Hassanein M, Reynoso J, Osawa Y, Nagaki M, Moriwaki H, et al.
Anticancer Res
. 2012 Jan;
32(1):31-8.
PMID: 22213285
The tumor microenvironment (TME) has an important influence on tumor progression. For example, we have discovered that passenger stromal cells are necessary for metastasis. In this report, we describe six...
4.
Watanabe N, Takai K, Imai K, Shimizu M, Naiki T, Nagaki M, et al.
J Clin Biochem Nutr
. 2011 Dec;
49(3):153-8.
PMID: 22128212
Obesity and related adipocytokine disbalance increase the risk of hepatocellular carcinoma. To determine the impact of increased levels of leptin, an obesity-related adipocytokine, on the recurrence of hepatocellular carcinoma, we...
5.
Osawa Y, Kanamori H, Seki E, Hoshi M, Ohtaki H, Yasuda Y, et al.
J Biol Chem
. 2011 Aug;
286(40):34800-8.
PMID: 21841000
Nonalcoholic fatty liver disease is one of the most common liver diseases. L-tryptophan and its metabolite serotonin are involved in hepatic lipid metabolism and inflammation. However, it is unclear whether...
6.
Terakura Y, Shiraki M, Nishimura K, Iwasa J, Nagaki M, Moriwaki H
J Nutr Sci Vitaminol (Tokyo)
. 2011 Mar;
56(6):372-9.
PMID: 21422706
Energy malnutrition worsens survival in patients with liver cirrhosis, and is currently defined as non-protein respiratory quotient (npRQ) <0.85, as measured by indirect calorimetry. However, measurement of this npRQ is...
7.
Suetsugu A, Osawa Y, Nagaki M, Saji S, Moriwaki H, Bouvet M, et al.
J Cell Biochem
. 2011 Feb;
112(3):949-53.
PMID: 21328469
The tumor microenvironment (TME) is critical for tumor growth and progression. However, the formation of the TME is largely unknown. This report demonstrates a color-coded imaging model in which the...
8.
Osawa Y, Seki E, Kodama Y, Suetsugu A, Miura K, Adachi M, et al.
FASEB J
. 2010 Dec;
25(4):1133-44.
PMID: 21163859
Acid sphingomyelinase (ASM) regulates the homeostasis of sphingolipids, including ceramides and sphingosine-1-phosphate (S1P). Because sphingolipids regulate AKT activation, we investigated the role of ASM in hepatic glucose and lipid metabolism....
9.
Kimura K, Sekiguchi S, Hayashi S, Hayashi Y, Hishima T, Nagaki M, et al.
J Leukoc Biol
. 2010 Nov;
89(3):433-42.
PMID: 21106643
Although the innate immune system has been demonstrated to play important roles as the first line of defense against various infections, little is known about the interactions between intrahepatic inflammatory...
10.
Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, et al.
J Neurol
. 2010 Oct;
258(3):421-6.
PMID: 20938781
During the pre-symptomatic stage of Parkinson's disease (PD), the idiopathic PD related abnormal synuclein immunostaining is confined to the medulla oblongata and olfactory bulb, according to Braak. In the study...